USPTO serial 88170758
INTREXON
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCCLELLAN, MATTHEW D.
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INTREXON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DOYLE SIEVER
DOYLE SIEVER PRECIGEN, INC.20374 SENECA MEADOWS PARKWAYGERMANTOWN, MD 20876UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture, except fungicides, herbicides, insecticides and parasiticides; chemicals for use in food production, namely, chemical preparations for preserving foodstuffs, chemical products for stabilizing foodstuffs, chemical preparations for increasing the efficiency of food production, and chemical preparations for increasing the quality of foodstuffs; chemicals for converting natural gas and methane to higher complexity multi-carbon fuels and chemicals for energy conversion; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and microbes for industrial and agricultural applications; Biotechnologically-formed genes, microbes and enzymes for use in converting waste biomass to high value products; microbes used to repel and destroy insects, pest, and rodents | ACTIVE | — |
| 004 | Fuels and biofuels | ACTIVE | — |
| 005 | Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical reagents for medical and veterinary purposes; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes; Preparations for destroying and repelling insects, pests, and rodents; microbial-based preparations for destroying and repelling insects, pests, and rodents; plant-based preparations for destroying and repelling insects, pests, and rodents; ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions in transgenic plants, microbes, fungi and animals, and in cells of plants, microbes, fungi and animals; Chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research | ACTIVE | — |
| 040 | Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use; energy conversion, namely, biological conversion of natural gas and methane to higher complexity multi-carbon fuels and chemicals | ACTIVE | May 31, 2018 |
| 042 | Development of new technology for others in the fields of medicine, genetics, therapeutics, biotechnology, agriculture, energy, fuels, biofuels, biochemistry, the chemical industry, and the environment; Research and development of environmentally friendly forms of energy and power; Development of products being genetic approaches and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize cell function or disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical, veterinary, and laboratory use; Scientific research and product development services for others in the pharmaceutical, chemical, biochemical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory use; Providing temporary use of non-downloadable computer software for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, fuels, biofuels, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for generating and tracking orders in the fields of chemical, biochemical, synthetic biology, energy, fuels, biofuels, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Computer services, namely, providing an interactive web site for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Computer services, namely, providing an interactive web site that allows users to view, store, and manage data in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology | ACTIVE | May 31, 2018 |
| 044 | Medical services; Medical services, namely, microbial, viral, protein, antibody, and gene therapy services | ACTIVE | May 31, 2018 |
| 045 | Licensing of intellectual property rights in the nature of technology transfer services of intellectual property | ACTIVE | May 31, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PRECIGEN, INC.
- Other trademarks owned by Intrexon Corporation
- Other trademarks owned by Intrexon Corporation
- Other trademarks in Class 001
- Other trademarks in Class 004
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named INTREXON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 7, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 19, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 19, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 20, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 20, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 18, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 18, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 18, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 18, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 8, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 17, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 17, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 13, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 4, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 4, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 4, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2018 | NWAP | NEW APPLICATION ENTERED | — |